SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-013652
Filing Date
2022-08-15
Accepted
2022-08-15 17:23:06
Documents
58
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q albo-20220630x10q.htm   iXBRL 10-Q 1441073
2 EX-31.1 albo-20220630xex31d1.htm EX-31.1 10377
3 EX-31.2 albo-20220630xex31d2.htm EX-31.2 10342
4 EX-32.1 albo-20220630xex32d1.htm EX-32.1 10541
  Complete submission text file 0001558370-22-013652.txt   4837717

Data Files

Seq Description Document Type Size
5 EX-101.SCH albo-20220630.xsd EX-101.SCH 36793
6 EX-101.CAL albo-20220630_cal.xml EX-101.CAL 36636
7 EX-101.DEF albo-20220630_def.xml EX-101.DEF 135021
8 EX-101.LAB albo-20220630_lab.xml EX-101.LAB 315176
9 EX-101.PRE albo-20220630_pre.xml EX-101.PRE 232312
52 EXTRACTED XBRL INSTANCE DOCUMENT albo-20220630x10q_htm.xml XML 615050
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33451 | Film No.: 221166832
SIC: 2834 Pharmaceutical Preparations